首页> 外文期刊>The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation >Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
【24h】

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

机译:微肿瘤生长启动血管生成萌发,同时表达 VEGF、VEGF 受体-2 和血管生成素-2。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Tumors have been thought to initiate as avascular aggregates of malignant cells that only later induce vascularization. Recently, this classic concept of tumor angiogenesis has been challenged by the suggestion that tumor cells grow by co-opting preexisting host vessels and thus initiate as well-vascularized tumors without triggering angiogenesis. To discriminate between these two mechanisms, we have used intravital epifluorescence microscopy and multi-photon laser scanning confocal microscopy to visualize C6 microglioma vascularization and tumor cell behavior. To address the mechanisms underlying tumor initiation, we assessed the expression of VEGF, VEGF receptor-2 (VEGFR-2), and angiopoietin-2 (Ang-2), as well as endothelial cell proliferation. We show that multicellular aggregates (<< 1 mm(3)) initiate vascular growth by angiogenic sprouting via the simultaneous expression of VEGFR-2 and Ang-2 by host and tumor endothelium. Host blood vessels are not co-opted by tumor cells but rather are used as trails for tumor cell invasion of the host tissue. Our data further suggest that the established microvasculature of growing tumors is characterized by a continuous vascular remodeling, putatively mediated by the expression of VEGF and Ang-2. The results of this study suggest a new concept of vascular tumor initiation that may have important implications for the clinical application of antiangiogenic strategies.
机译:肿瘤被认为是恶性细胞的无血管聚集体,后来才诱导血管形成。最近,肿瘤血管生成的这一经典概念受到以下建议的挑战:肿瘤细胞通过选择预先存在的宿主血管生长,从而在不触发血管生成的情况下启动血管化良好的肿瘤。为了区分这两种机制,我们使用活体落射荧光显微镜和多光子激光扫描共聚焦显微镜来可视化 C6 小胶质细胞瘤血管形成和肿瘤细胞行为。为了解决肿瘤起始的潜在机制,我们评估了 VEGF、VEGF 受体-2 (VEGFR-2) 和血管生成素-2 (Ang-2) 的表达,以及内皮细胞增殖。我们发现多细胞聚集体(<< 1 mm(3))通过宿主和肿瘤内皮同时表达 VEGFR-2 和 Ang-2 通过血管生成萌发启动血管生长。宿主血管不被肿瘤细胞所吸收,而是被用作肿瘤细胞侵袭宿主组织的踪迹。我们的数据进一步表明,生长肿瘤的已建立微血管系统的特征是连续的血管重塑,推测由 VEGF 和 Ang-2 的表达介导。本研究结果提出了一种新的血管肿瘤起始概念,可能对抗血管生成策略的临床应用具有重要意义。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号